Abstract
Introduction
Recognition of viral RNA in infected cells results in activation of interferon-regulatory factors (IRF) and induction of type I IFN, which initiates potent antiviral responses (Honda et al., 2006; Rathinum &Fitzgerald, 2011) . sense cytoplasmic viral RNA to activate IRF3/7 through the adaptor MAVS, while TLR3 recognizes extracellular RNA to signal IRF3/7 through the adaptor TICAM-1 (Kawai & Akira, 2006; . Each virus species has its own strategy to circumvent IFN induction, thereby successfully replicating in host cells.
Measles virus (MV) is a negative-strand RNA virus, that infects human cells and rapidly induces a Th1 response in children which is characterized by high levels of interferon (IFN)- and IL-2 in the early phase (Griffin et al., 1990) . Paradoxically, MV infection is also accompanied by a severe suppression of the immune response that may last for months and this increases the vulnerability to secondary life-threatening infections (Schneider-Schaulies et al., 1995; Moss et al., 2004) . Although consensus conclusions are limited in this issue, host dendritic cells (DCs) and acute type I IFN/IL-10 responses are critically implicated in a MV-mediated immune modulation.
It has been reported that V protein of MV wild-type strains blocks IFN-inducing signaling, thereby most wild-type strains can replicate in human cells without interfering with typeI IFN (Takeuchi et al., 2003; Shingai et al., 2007; Ikegame et al., 2010) . Several laboratory-adapted strains of MV which produce defective interfering (DI) RNA , and a rescued strain called Edmonston tag (Radecke et al., 1995) that harbors C272R-mutated V protein (Ohno et al., 2004) , induces type I IFN and explains the mechanism of IFN induction by this MV clone (Takaki et al., 2011) .
Cytoplasmic RNA sensors, RIG-I and MDA5, are involved in MV RNA recognition and following type I IFN induction (Ikegame et al., 2010) , that causes IFNAR-mediated amplification (Takeuchi et al., 2003) . RIG-I and MDA5 deliver signals through mitochondrial antiviral signaling protein (MAVS, also called IPS-1/Cardif/VISA) (Yoneyama et al., 2008) . Minimal participation of TLRs in MV replication has been reported in human cells including macrophages and dendritic cells (Murabayashi et al., 2002; Tanabe et al., 2003) .
The dsRNA-sensing system is believed to be essentially the same in the human and mouse, except that the type I IFN basal level is relatively high in the intact mouse (Shingai et al., 2005) . We have made mouse models for analysis of immune aberration induced by various virus infections . Human CD150 is a main entry receptor for MV, and expressed on DCs, macrophages, T and B cells, (Tatsuo et al., 2000) . Ifnar -/-mice with transgenic human CD150 (CD150Tg/Ifnar -/-) have been used as a MV infection model mouse (Welstead et al., 2005; Shingai et al., 2005; Sellin et al, 2009; Koga et al., 2010) and shown that bone marrow-derived (BM)DCs are highly susceptible to MV (Shingai et al., 2005) as in human monocyte-derived or CD34 + progenitor-derived DCs (Fugier-Vivier et al., 1997; Grosjean et al., 1997) . Actually, transfer of MV-infected BMDCs to CD150Tg/Ifnar -/-mice facilitates establishing systemic MV infection in mice (Shingai et al., 2005) .
Here, we generated CD150Tg/Mavs 
Materials and Methods

Mice
All knockout mice were backcrossed with C57BL/6 mice more than eight times before use. CD150Tg (Shinagi et al., 2005) , Ticam1 -/- (Akazawa et al., 2007) and mice were generated in our laboratory. Irf3
-/-/Irf7 -/-double knockout (DKO) mice (Sato et al., 2000) and IL-10 Venus mice (Atarashi et al., 2011) were provided by Dr. T. Taniguchi (University of Tokyo, Tokyo, Japan) and Dr. K. Center, Hokkaido University, Japan. All mice were used according to the guidelines of the Institutional Animal Care and Use Committee of Hokkaido University, who approved this study as no.08-0244. All inoculation and experimental manipulation was performed under anesthesia that was induced and maintained with pentobarbital sodium, and all efforts were made to minimize suffering. All mice were maintained under specific pathogen-free conditions in the Animal Facility at Hokkaido University Graduate School of Medicine (Sapporo, Japan) and used when they were between 6 and 12 weeks of age.
Cell culture
Vero/CD150 was maintained in DMEM supplemented with 10% heat-inactivated FBS and antibiotics. BMDCs were generated from bone marrow according to the method described by Inaba et al. (1992) , with slight modifications. Briefly, bone marrow samples from the femurs and tibiae of mice were cultured in RPMI 1640 (Sigma) with 10% heat-inactivated FBS containing GM-CSF (J558 supernatant) for 6 days with replenishment of the medium every other day. Splenic naïve CD4 + CD25 -T cells were isolated by negative selection using the biotin-CD8a, CD11b, B220, Dx5, Gr1, CD25 anitbody and streptavidin beads (Miltenyi Biotec) (typically > 90% purity) (Akazawa et al., 2007) . For coculture experiment, 2 x 10 5 CD4 + T cells and 1 x 10 4 mock or with MV-infected BMDCs were cocultured with or without anti-CD3 antibody (0.1 g/ml) for 4 or 6 days. For restimulation, 4 x 10 5 CD4 + T cells were cultured with the plate bound anti-CD3 antibody (0 -1 g/ml) for 48 hours.
Virus
Vero/CD150 was maintained in DMEM supplemented with 10% heat-inactivated fetal bovine serum and antibiotics. MV323, corresponding to the IC-B strain of MV was recovered from the plasmid p(+)MV323 encoding the antigenomic IC-B sequence (Takeda et al, 2000) . MV323 luciferase was kindly gifted from Dr. M. Takeda (Department of Virology III, National Institute of Infectious Disease, Tokyo, Japan) (Takeda et al., 2007) . MV323-luciferase and MV 323-GFP (Shingai et al., 2005) were maintained in Vero/CD150 cells . Virus titer was determined as plaque forming units (PFUs) on Vero/CD150 and the MOI of each experiment was calculated based on this titer (Kobune et al., 1990) . To measure the efficiency of in vitro infection, cells (5 x 10 4 to 2 x 10 5 ) were harvested in 25 l of lysis buffer for luciferase assays. Luciferase assays were performed using a Dual-Luciferase reporter assay system (Promega), and luciferase activity was read using Lumat LB 9507 (Berthold Technologies). Luciferase activity is shown as means ± S.D. of three samples.
In vivo infection and BMDCs transfer
Six-to 12-week-old mice were used throughout this study. Mice were infected i.p.
with MV323-GFP at dose of 1 x 10 6 pfu. At 3 and 6 days after inoculation, sera were collected from MV-or mock-infected mice. 
ELISA
Culture supernatants of cells (3 -5 x 10 5 ) seeded on 24-well plates were collected and analyzed for cytokine levels with enzyme-linked immunosorbent assay (ELISA).
ELISA kits for mouse IFN- and IFN- were purchased from PBL Biomedical Laboratories. ELISA kits for mouse IL-10, IL-13 and IFN- were purchased from eBiosciences. ELISA was performed according to the manufacturer's instructions.
RT-PCR and Real-time PCR
Total RNA was prepared using TRIzol Reagent (Invitrogen) following the manufacturer's instructions. RT-PCR was carried out using the High Capacity cDNA
Reverse Transcripition kit (Applied Biosystems) according to the manufacturer's instructions. The nucleotide sequences of the primers for real-time PCR are shown in supplemental Table I . Real-time PCR was performed using a Step One real-time PCR system (Applied Biosystems). Expression levels of target mRNA were normalized to -actin and fold inductions of transcripts were calculated using the ddCT method relative to unstimulated cells.
FACS analysis
BMDCs were stained with anti-CD11c-APC (eBiosciences) and anti-human CD150-FITC (eBiosciences) and fluorescence intensity was measured by FACS Calibur.
For Foxp3 intracellular staining, cells were stained with anti-CD25-PE (eBiosciences),
anti-CD4-FITC (eBiosciences) and anti-Foxp3-APC using Foxp3 staining kit (eBiosciences). For IFN- intracellular staining, cells were stained with anti-IFN--APC using BD Cytofix/Cytoperm kit (BD Biosciences). Stained cells were analyzed by flow cytometry.
Statistical Analyses
Statistical significance of differences between groups was determined by the Student t test using Microsoft Excel software. Values of p < 0.05 were considered significant. (Sato et al., 2000) . However, MV only marginally infected the BMDCs derived from the CD150Tg/Irf3
Results
CD150Tg/Mavs
-/-/Irf7 -/-mice (Fig. 1B) . The CD150Tg/Ticam1
-/-BMDCs were hardly as permissive to MV as CD150Tg BMDCs (Fig. 1B) .
Approximately 6% of CD150Tg/Mavs -/-BMDCs were infected with MV and the infection efficiency in CD150Tg/Mavs -/-BMDCs was comparable to that in CD150Tg/Ifnar -/-BMDCs (Fig. 1B) . A previous report suggested that the IFN-inducing pathway in CD11c + BMDCs is critically implicated in establishment of MV infection (Shingai et al., 2005) . Here, we show the molecular evidence that MAVS and IFNAR are crucial for protection against MV.
To confirm the efficiency of MV-GFP infection in BMDCs, we used a recombinant MV-luciferase which encodes the reporter Renilla luciferase (Takeda et al., 2007) . Luciferase activity obtained from MV-infected Vero cells was correlated with the viral titer of MV-infected cells (Supplemental Fig. 2 ). MV-luciferase BMDCs were infected with MV-luciferase at MOI of 0.25 for 24 hours and luciferase activity was measured (Fig. 1C) . As similar to the results from MV-GFP infection, CD150Tg, and The effect of the anti-IFNAR antibody on MV infection in CD150Tg/Mavs -/-BMDCs was weak (Fig. 2C ). These results were confirmed by using MV-luciferase (Supplemental Fig. 4 ). These data suggest that MV infection induces IFN- production in BMDCs in part independent of IRF3/IRF7. In contrast, due to the absence of IFN-/ induction in the MV-infected CD150Tg/Mavs -/-BMDCs ( Fig (Fig. 3E) . c-Maf mRNA, a master regulator of Tr1, and Rorgt mRNA, a master regulator of Th17, and Foxp3 mRNAs were decreased in CD4 + T cells cocultured with BMDCs (Fig. 3E) . The expression level of T-bet mRNA, a master regulator of Th1, was increased when naïve CD4 + T cells were cocultured with BMDCs (Fig. 3E ). Taken together, the results indicate that MV-infected BMDCs affect naïve CD4 + T cells in such a manner as to induce IL-10-and IFN--producing T cells without any induction of Treg. Although recent reports have demonstrated that IL-27 promotes IL-10 production by CD4 + T cells (Stumhofer et al., 2007; Fitzgerald et al., 2007; Awasthi et al., 2007) , in this setting, IL-27 only partially contributed to MV-induced IL-10 production (Supplemental Fig. 6 ).
CD4 + T cells produced IL-10 in response to MV infection
The IL-10 level in the serum prepared from MV-infected CD150Tg/Ifnar -/-mice was not different from the level in mock-infected mice (Fig. 4A ). To identify cell types that produce IL-10, we isolated subsets of the splenocytes from MV-or (Fig. 4C) . Moreover, IL-10 producing CD4 + T cells were different subsets from IFN- producing T cells (Fig. 4D ).
Discussion
We have demonstrated that CD150Tg/Mavs -/-BMDCs were permissive to MV (Oshiumi et al., 2003) . Although TLR3/TICAM-1 participate in BMDC maturation in response to cell-derived virus RNA in RNA virus infections (Ebihara et al., 2008; Oshiumi et al., 2011) , this is not the case in MV infection. , 2013) . IRF1 is also involved in TLR9-mediated IFN- production in BMDCs (Schmitz et al., 2007) . In the case of MV infection, IRF5
and IRF1 might be candidate transcription factors for MAVS-dependent and IRF3/IRF7-independent type I IFN induction in BMDCs.
In this context, we looked for possible transcription factors other than typical type I IFN production in laboratory-adapted or genetically-mutated MV strains (Takaki et al., 2011; Shingai et al., 2005) , but there appears to be no in vivo data supporting this finding. In general, each cell type has its own dominant IFN-inducing systems by which viral infections are differentially sensed and rapidly prevented in a cell-specific manner.
Here, we show that the MAVS-dependent but IRF-3/7-independent IFN- production actually does function in CD150Tg BMDCs in response to MV infection, this pathway being unique to BMDCs for primary MV protection. Secondary protection against MV spreading to other cells is accomplished by IFNAR which prevents systemic MV infection due to BMDC transfer. It will be of interest to determine whether the results are reproducible in other DC subsets in the mouse MV-infection model.
In patients with measles, alteration of the cytokine profile has been reported earlier (Griffin et al., 1990) . The early Th1 response is shifted to a Th2 response, which occurs during the late stages of measles, with an increase in the secretion of IL-4 and a decrease in the IL-12 levels (Naniche and Oldstone, 2000; Atabani et al., 2001 ).
Consistent with these reports, we detected a high level of IL-13 production in the coculture supernatant of CD4 + T cells and MV-infected BMDCs (data not shown). The plasma level of the anti-inflammatory cytokine IL-10 is increased in patients with measles (Atabani et al., 2001; Yu et al., 2008) . This elevated level of plasma IL-10 probably contributes to the impaired cellular immunity and depressed hypersensitivity response following MV infection (Ryon et al., 2002) . However, the primary DC response and source of IL-10 in MV-infected patients is at present not clear. CD150Tg/Mavs -/-BMDCs completely lack the ability to produce type I IFN, and thereby are permissive to MV infection ( Fig. 2A and B) . 
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